Withings Health Solutions proudly announced FDA clearance for their innovative cellular blood pressure monitor, BPM Pro 2. This breakthrough device aims to transform clinical workflows by offering seamless measurement of blood pressure and pulse rate for adults with varying arm sizes.
The introduction of BPM Pro 2 aids in expanding the reach of remote patient monitoring while simplifying the healthcare process. Patients can now conduct accurate blood pressure measurements at home under ideal conditions. A newly incorporated Patient Insights feature enriches the data gathering process, adding valuable context from everyday life.
Patient Insights poses inquiries about symptoms and medication adherence, facilitating a more holistic understanding of results and decreasing clinical workloads. It automates essential tasks for healthcare teams, blending real-time data collection with practical insights.
By automating functions such as symptom tracking and sending measurement reminders, the device lessens the necessity for manual patient outreach, allowing healthcare professionals to concentrate on quality care delivery. Other notable features include customized health suggestions, user-friendly design, and flawless connectivity.
“The FDA’s approval of BPM Pro 2 is a major leap forward in remote patient monitoring. This device not only provides precise clinical metrics but also equips healthcare teams with real-time insights and tools for direct patient interaction,” stated Antoine Robiliard, VP of Withings Health Solutions. “Celebrating this milestone alongside recognition as a CES 2025 Innovation Awards Honoree reaffirms our dedication to developing solutions that simplify processes, enhance patient participation, and set higher standards for remote care quality and dependability.”